
Alvotech launches Simponi biosimilar in Europe
Biotechnology company Alvotech has announced the European launch of its first-in-market biosimilar to Simponi (golimumab). AVT05, known as Gobivaz, is a prefilled syringe and autoinjector used for the treatment of adults with rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, as well as in children with ulcerative colitis. Gobivaz becomes the first marketed biosimilar to… Read More















